Top

Journal of Neurology

Published in:

01-05-2013 | Letter to the Editors

Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls

Authors: Lucía F. Cardo, Eliecer Coto, Lorena de Mena, Renée Ribacoba, Germán Moris, Manuel Menéndez, Victoria Alvarez

Published in: Journal of Neurology | Issue 5/2013

Excerpt

Dear Sirs, …

Available only for authorised users

Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134PubMedCrossRef

Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31:763–780PubMedCrossRef

Eacker SM, Dawson TM, Dawson VL (2009) Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 10:837–841PubMed

Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317:1220–1224PubMedCrossRef

Wang G, van der Walt JM, Mayhew G, Li YJ, Zuchner S, Scott WK, Martin ER, Vance JM (2008) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 82:283–289PubMedCrossRef

Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM (2009) Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 106:13052–13057PubMedCrossRef

Gehrke S, Imai Y, Sokol N, Lu B (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466:637–641PubMedCrossRef

Minones-Moyano E, Porta S, Escaramis G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Marti E (2011) MicroRNA profiling of Parkinson’s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 20:3067–3078PubMedCrossRef

Reid G, Kirschner MB, van Zandwijk N (2011) Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 80:193–208PubMedCrossRef

10.

Olivieri F, Spazzafumo L, Santini G, Lazzarini R, Albertini MC, Rippo MR, Galeazzi R, Abbatecola AM, Marcheselli F, Monti D, Ostan R, Cevenini E, Antonicelli R, Franceschi C, Procopio AD (2012) Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 133:675–685PubMedCrossRef

11.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef

12.

Geekiyanage H, Jicha GA, Nelson PT, Chan C (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer’s disease. Exp Neurol 235:491–496PubMedCrossRef

13.

Li X, Khanna A, Li N, Wang E (2011) Circulatory miR34a as an RNA based, noninvasive biomarker for brain aging. Aging (Albany NY) 3:985–1002

14.

Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, Vance JM, Outeiro TF, Wang L, Borovecki F, Ferreira JJ, Oliveira SA (2011) Convergence of miRNA expression profiling, alpha-synuclein interaction and GWAS in Parkinson’s disease. PLoS ONE 6:e25443PubMedCrossRef

15.

Margis R, Rieder CR (2011) Identification of blood microRNAs associated to Parkinson’s disease. J Biotechnol 152:96–101PubMedCrossRef

Title: Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls
Authors: Lucía F. Cardo
Eliecer Coto
Lorena de Mena
Renée Ribacoba
Germán Moris
Manuel Menéndez
Victoria Alvarez
Publication date: 01-05-2013
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 5/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-013-6900-8

At a glance: The STEP trials

Springer Medicine

Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2013

Multiple sclerosis and pregnancy: therapeutic considerations

Early sleep apnea screening on a stroke unit is feasible in patients with acute cerebral ischemia

Thrombolysis for stroke caused by infective endocarditis: an illustrative case and review of the literature

Anders Retzius (1796–1860)

Cognitive outcome of survivors of space-occupying hemispheric infarction

Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation